Search results for "ischemic attack"

showing 10 items of 84 documents

Role of Associated Cortical Lesions in Motor Partial Seizures and Lenticulostriate Infarcts

1995

In a population-based study, we evaluated seizures occurring in the first 15 days after strokes among 1,640 consecutive patients who had ischemic (814 infarcts with atheroma and 126 with cardiogenic embolism, 273 lacunar infarcts, 259 transient ischemic attacks) or hemorrhagic stroke (129 supratentorial hematomas and 24 subarachnoïd hemorrhage) on computed tomography (CT) scan. Ninety patients had an epileptic seizure in the first 15 days after stroke onset. Thirteen of the 90 had a lenticulostriate infarct, diagnosed on CT scan, without an apparent ipsilateral cortical ischemic lesion. No lenticulostriate hematoma was observed with seizures. To determine the possible existence of an ipsila…

Malemedicine.medical_specialtyPathologySubarachnoid hemorrhagePopulationFunctional LateralityCentral nervous system diseaseEpilepsyHematomamedicineHumanscardiovascular diseaseseducationStrokeAgedTomography Emission-Computed Single-Photoneducation.field_of_studymedicine.diagnostic_testbusiness.industryElectroencephalographyMagnetic resonance imagingCerebral InfarctionIntracranial Embolism and Thrombosismedicine.diseaseMagnetic Resonance ImagingCerebrovascular DisordersNeurologyIschemic Attack TransientFemaleEpilepsies PartialNeurology (clinical)RadiologyEpileptic seizuremedicine.symptomTomography X-Ray ComputedbusinessEpilepsia
researchProduct

Time Trends in Hospital-Referred Stroke and Transient Ischemic Attack: Results of a 7-Year Nationwide Survey in France

2010

<i>Background:</i> Nationwide evaluations of the burden of stroke are scarce. We aimed to evaluate trends in stroke and transient ischemic attack (TIA) hospitalization, in-hospital case fatality rates (CFRs) and mortality rates in France during 2000–2006. <i>Methods:</i> Hospitalizations for stroke and TIA were determined from National Hospital Discharge Diagnosis Records that used the International Classification of Disease, 10th revision, codes I60, I61, I63, I64, G45, G46. CFRs and mortality rates were estimated from the national death certificates database. <i>Results:</i> The total number of stays for stroke increased between 2000 and 2006 (88,371 vs…

Malemedicine.medical_specialtyPediatrics030204 cardiovascular system & hematologyStroke mortalityNationwide survey03 medical and health sciences0302 clinical medicineHealth care policyEpidemiologymedicineHumansOrganized stroke careLongitudinal Studiescardiovascular diseasesTransient ischemic attackStrokeAgedRetrospective StudiesAged 80 and overHospital stayIn hospital mortalityStroke epidemiologyTime trendsbusiness.industryRetrospective cohort studyLength of Staymedicine.diseaseHealth Surveysnervous system diseases3. Good healthHospitalizationSurvival RateStrokeIn-hospital mortalityNeurologyIschemic Attack TransientTissue Plasminogen ActivatorIncidence and mortality ratesFemale[SDV.SPEE]Life Sciences [q-bio]/Santé publique et épidémiologieNeurology (clinical)FranceCardiology and Cardiovascular MedicinebusinessHospital stay030217 neurology & neurosurgery
researchProduct

Postischemic application of lipid peroxidation inhibitor U-101033E reduces neuronal damage after global cerebral ischemia in rats.

1998

Background and Purpose —The lipid peroxidation inhibitor U-101033E was examined for effects on cerebral blood flow (CBF), cortical tissue hemoglobin oxygen saturation (HbS o 2 ), and neuronal damage. Methods —Fifteen minutes of global cerebral ischemia was induced by two-vessel occlusion and hypobaric hypotension. Wistar rats (n=25) were randomized to receive vehicle (n=9) or 40 mg/kg U-101033E (n=9) intraperitoneally during 2 hours of reperfusion. A sham group (n=7) had neither ischemia nor therapy. Histology was evaluated 7 days after ischemia. Results —During late hyperperfusion (at 17 minutes), vehicle-treated animals had a higher ( P =0.044) cortical tissue HbS o 2 (72.0±1.4%) than di…

Malemedicine.medical_specialtyPyrrolidinesVasodilator AgentsIschemiaCell CountHippocampal formationAntioxidantsCentral nervous system diseaseLipid peroxidationchemistry.chemical_compoundCortex (anatomy)Internal medicinemedicineLaser-Doppler FlowmetryAnimalsRats WistarAdvanced and Specialized NursingNeuronsbusiness.industryCarbon Dioxidemedicine.diseaseSurgeryRatsEndocrinologymedicine.anatomical_structureNeuroprotective AgentsPyrimidinesCerebral blood flowchemistryCerebral cortexIschemic Attack TransientCerebrovascular CirculationOxyhemoglobinsNeurology (clinical)Lipid PeroxidationHypotensionCardiology and Cardiovascular MedicinebusinessReperfusion injuryStroke
researchProduct

Neurological complications of Anderson-Fabry disease

2012

Characteristic clinical manifestations of AFD such as acroparesthesias, angiokeratoma, corneal opacity, hypo/ and anhidrosis, gastrointestinal symptoms, renal and cardiac dysfunctions can occur in male and female patients, although heterozygous females with AFD usually seems to be less severely affected. The most prominent CNS manifestations consist of cerebrovascular events such as transient ischaemic attacks (TIAs) and (recurrent) strokes . For the most part, CNS complications in AFD have been attributed to cerebral vasculopathy, including anatomical abnormalities. The natural history of Fabry patients includes transitory cerebral ischaemia and strokes, even in very young persons of both …

Malemedicine.medical_specialtySettore MED/09 - Medicina InternaPopulationTransient ischaemic attacksPulvinarSeverity of Illness IndexInternal medicineDrug DiscoverymedicinePrevalenceHumanseducationStrokeDepression (differential diagnoses)Pharmacologyeducation.field_of_studySex Characteristicsbusiness.industryAge Factorsmedicine.diseaseFabry diseaseHyperintensitySurgeryAngiokeratomaStrokePeripheral neuropathyIschemic Attack TransientCerebrovascular Circulationalpha-GalactosidaseCardiologyFabry DiseaseFemaleAnderson-Fabry disease Neurological strokebusiness
researchProduct

Dietary phytoestrogens improve stroke outcome after transient focal cerebral ischemia in rats.

2006

As phytoestrogens are postulated as being neuroprotectants, we assessed the hypothesis that dietary isoflavone-type phytoestrogens are neuroprotective against ischemic stroke. Transient focal cerebral ischemia (90 min) was induced by middle cerebral artery occlusion (MCAO) following the intraluminal thread technique, both in rats fed with soy-based diet and in rats fed with isoflavone-free diet. Cerebro-cortical laser-Doppler flow (cortical perfusion, CP), arterial blood pressure, core temperature, PaO2, PaCO2, pH and glycemia were measured before, during and after MCAO. Neurological examination and infarct volume measurements were carried out 3 days after the ischemic insult. Dietary isofl…

Malemedicine.medical_specialtyTime FactorsIschemiaNeurological examinationPhytoestrogensNeuroprotectionchemistry.chemical_compoundInternal medicineStroke outcomemedicineLaser-Doppler FlowmetryAnimalsRats WistarChromatography High Pressure LiquidNeurologic Examinationmedicine.diagnostic_testbusiness.industryGeneral NeuroscienceNeurological statusBody WeightCerebral InfarctionIsoflavonesmedicine.diseaseDietRatsStrokeDisease Models AnimalBlood pressureEndocrinologyNeuroprotective AgentschemistryIschemic Attack TransientAnesthesiaReperfusionPhytoestrogensbusinessThe European journal of neuroscience
researchProduct

Long‐Term Risk of Myocardial Infarction Compared to Recurrent Stroke After Transient Ischemic Attack and Ischemic Stroke: Systematic Review and Meta‐…

2018

Background Uncertainties remain about the current risk of myocardial infarction ( MI ) after ischemic stroke or transient ischemic attack. Methods and Results We undertook a systematic review to estimate the long‐term risk of MI , compared to recurrent stroke, with temporal trends in ischemic stroke/transient ischemic attack patients. Annual risks and 95% confidence intervals (95% CI ) of MI and recurrent stroke were estimated using random‐effect meta‐analyses. We calculated incidence ratios of MI /recurrent stroke, for fatal and nonfatal events, using similar analyses. Rate ratios for MI in patients with potential risk factors compared to those without were calculated using Poisson regres…

Malemedicine.medical_specialtyTime FactorsMyocardial Infarctionischemic030204 cardiovascular system & hematologyRisk AssessmentBrain IschemiaBrain ischemia03 medical and health sciences0302 clinical medicineRecurrenceRisk FactorsRecurrent strokeCause of DeathInternal medicineSecondary PreventionmedicineHumansMyocardial infarctionStrokeAgedIschemic StrokeCause of deathSystematic Review and Meta‐Analysisbusiness.industryIncidenceTransient Ischemic Attack (TIA)Middle AgedPrognosismedicine.diseasestrokeIschemic Attack TransientMeta-analysisIschemic strokeCardiologyFemaleCardiology and Cardiovascular MedicineRisk assessmentbusiness030217 neurology & neurosurgeryJournal of the American Heart Association
researchProduct

Insights from Experiences on Antiplatelet Drugs in Stroke Prevention: A Review

2020

Reduction of hazard risk of cerebral ischemic event (stroke, transient ischemic attack (TIA)) represents the hard point to be achieved from primary or secondary preventive strategy in the best clinical practice. However, results from clinical trials, recommendations, guidelines, systematic review, expert opinions, and meta-analysis debated on the optimal pharmacotherapy to achieve the objective. Aspirin and a number of antiplatelet agents, alone or in combination, have been considered from large trials focused on stroke prevention. The present review summarizes, discusses results from trials, and focuses on the benefits or disadvantages originating from antiplatelet drugs. Sections of the r…

Malemedicine.medical_specialtyaspirinHealth Toxicology and Mutagenesisdipyridamolelcsh:MedicineStroke.Review030204 cardiovascular system & hematology03 medical and health sciencesTherapeutic approach0302 clinical medicinePharmacotherapyDouble-Blind MethodpreventionSecondary PreventionmedicineHumanscardiovascular diseasesIntensive care medicineStrokeAgedclopidogrelAspirinPreventive strategybusiness.industrylcsh:RPublic Health Environmental and Occupational HealthMiddle AgedClopidogrelmedicine.diseasestrokecombined drug therapyClinical trialDiabetes Mellitus Type 2Ischemic Attack TransientStroke preventionDrug Therapy CombinationFemalebusinesscilostazolPlatelet Aggregation Inhibitors030217 neurology & neurosurgerymedicine.drugInternational Journal of Environmental Research and Public Health
researchProduct

Suppression of ischemia-induced fos expression and AP-1 activity by an antisense oligodeoxynucleotide to c-fos mRNA.

1994

The molecular events of brain adaptation to injury that may underlie functional recovery after stroke remain largely undefined. Recent observations of altered gene expression in ischemic brain using animal stroke models have opened new avenues for exploration of the biochemical cascades after stroke [1–11]. These postischemic events include an increase in extracellular excitatory amino acid neurotransmitters such as glutamate. Glutamate receptor–mediated activation of phospholipases and protein kinases results in the alteration of nuclear regulatory processes, including the expression of immediate early genes such as c-fos, junB, and c-jun [5, 12]. The Fos, Jun, and JunB proteins have been …

Messenger RNAbiologyBase SequenceJUNBEffectorOligonucleotideMolecular Sequence DataGene ExpressionOligonucleotides Antisensec-FosMolecular biologyReceptor tyrosine kinaseArticleRatsTranscription Factor AP-1NeurologyTranscription (biology)Ischemic Attack TransientGene expressionbiology.proteinAnimalsNeurology (clinical)RNA MessengerProto-Oncogene Proteins c-fosAnnals of neurology
researchProduct

Epidemiology of stroke and transient ischemic attacks: Current knowledge and perspectives

2015

International audience; Because of the growing size and aging of the world's population, the global burden of stroke is increasing dramatically. Current epidemiological data indicate that 16.9 million people suffer a stroke each year, which represents a global incidence of 258/100,000 year, with marked differences between high- and low-income countries, and an age-adjusted incidence 1.5 times higher in men than in women. Although primary prevention has contributed to a decrease in stroke incidence in high-income countries, the so-called 'epidemiological transition' has led to an increase in incidence in middle-to-low-income countries as well. In addition, the incidence of ischemic stroke in…

Pediatricsmedicine.medical_specialtyEpidemiologylate 20th-centuryPopulationPsychological intervention030204 cardiovascular system & hematologyGlobal Health03 medical and health sciences0302 clinical medicineetiologic subtypescaribbean population[ SDV.MHEP ] Life Sciences [q-bio]/Human health and pathologyEpidemiologymedicineGlobal healthPrevalenceHumansMortality30-day case-fatalityeducationTransient ischemic attackrisk-factorsStrokeDepression (differential diagnoses)education.field_of_studybusiness.industrycommunity strokeIncidence (epidemiology)Incidencecase-fatality ratesmedicine.disease3. Good healthStrokeEpidemiological transitionNeurologyRisk factorsIschemic Attack Transientquality-of-life1st-ever strokeNeurology (clinical)Francebusiness28-day case-fatality030217 neurology & neurosurgery[SDV.MHEP]Life Sciences [q-bio]/Human health and pathologyDemography
researchProduct

Long-term performance of the bovine pericardium patch in conventional carotid endarterectomy.

2014

Objective The aim of the study was to analyze long-term results of carotid endarterectomy (CEA) using bovine pericardium patch. Patients and Methods This study is a retrospective analysis of 274 consecutive cases (173 in CEA group and 101 patients in an internal control group of eversion endarterectomy [EEA]) operated between January 2005 and May 2007. Operations were performed according to standard surgical technique. Primary endpoints of the study were 30-day mortality, ipsilateral neurologic event rate, and high-grade restenosis in the long-term follow-up. Results No statistically significance between both groups was found in terms of gender, age, risk factors, medication (statine, plate…

Pulmonary and Respiratory MedicineAdultMalemedicine.medical_specialtyTime Factorsmedicine.medical_treatmentCarotid endarterectomyKaplan-Meier EstimateRestenosisRecurrenceRisk FactorsInternal medicinemedicinePericardiumAnimalsHumansCarotid StenosisStrokeEndarterectomyAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overEndarterectomy Carotidbusiness.industryProportional hazards modelRetrospective cohort studyPerioperativeMiddle Agedmedicine.diseaseSurgeryStrokemedicine.anatomical_structureTreatment OutcomeIschemic Attack TransientCardiologySurgeryCattleFemaleCardiology and Cardiovascular MedicinebusinessPericardiumThe Thoracic and cardiovascular surgeon
researchProduct